Green Thumb, Trulieve and other cannabis stocks up as much as 13% as details emerge on HHS recommendation to lower drug classification
The release of documents that support a recommendation by the U.S. Department of Health and Human Services to lower the classification of cannabis under federal law to Schedule III from Schedule I ig…